The acquisition is expected to expand Medtronic’s surgical technologies business unit portfolio of treatments for sleep-disordered breathing.
The Repose Genioglossus Advancement and Hyoid Advancement (GAHA) surgical devices advance the base of the tongue and the hyoid bone to prevent obstructions of the airway during sleep.
In addition to the Repose System, the surgical technologies business of Medtronic offers the Pillar Palatal Implant System, used to treat the soft palate component of sleep breathing disorders, and an existing family of market-leading ENT instruments used to treat other upper airway obstructions.
Bob Blankemeyer, president of the surgical technologies business and senior vice president at Medtronic, said: “The Repose GAHM devices provide our surgeon customers with another minimally invasive, low morbidity option to treat patients suffering from obstructive sleep apnea.”